Literature DB >> 12684737

Acute mania is accompanied by elevated glutamate/glutamine levels within the left dorsolateral prefrontal cortex.

Nikolaus Michael1, Andreas Erfurth, Patricia Ohrmann, Michael Gössling, Volker Arolt, Walter Heindel, Bettina Pfleiderer.   

Abstract

RATIONALE: The dorsolateral prefrontal cortex (DLPFC) participates in the pathophysiology of mania. In particular, left-sided structural and metabolic abnormalities have been described.
OBJECTIVES: Clinical symptoms may be due to hyperactivity of cortical glutamatergic neurons, resulting in increased excitatory neurotransmitter flux and thus enhanced Glx levels.
METHODS: Glutamate/glutamine (Glx) levels were assessed by proton magnetic resonance spectroscopy ((1)H-MRS) in eight acute manic patients compared with age- and gender-matched controls.
RESULTS: Manic patients had significantly elevated Glx levels ( t-test; t=-3.1, P=0.008) within the left DLPFC.
CONCLUSIONS: Our results indicate that the prefrontal cortical glutamatergic system is involved in the pathophysiology of acute mania. This may have implications for the treatment of mania.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12684737     DOI: 10.1007/s00213-003-1440-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  20 in total

1.  Frontosubcortical neuroanatomy and the continuous performance test in mania.

Authors:  K W Sax; S M Strakowski; M E Zimmerman; M P DelBello; P E Keck; J M Hawkins
Journal:  Am J Psychiatry       Date:  1999-01       Impact factor: 18.112

2.  Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx.

Authors:  S Nonaka; C J Hough; D M Chuang
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-03       Impact factor: 11.205

3.  Cytoarchitectonic definition of prefrontal areas in the normal human cortex: II. Variability in locations of areas 9 and 46 and relationship to the Talairach Coordinate System.

Authors:  G Rajkowska; P S Goldman-Rakic
Journal:  Cereb Cortex       Date:  1995 Jul-Aug       Impact factor: 5.357

4.  Molecular abnormalities in the major psychiatric illnesses: Classification and Regression Tree (CRT) analysis of post-mortem prefrontal markers.

Authors:  M B Knable; B M Barci; J J Bartko; M J Webster; E F Torrey
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

Review 5.  Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments.

Authors:  J H Krystal; G Sanacora; H Blumberg; A Anand; D S Charney; G Marek; C N Epperson; A Goddard; G F Mason
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

6.  A neuropsychological investigation of prefrontal cortex involvement in acute mania.

Authors:  L Clark; S D Iversen; G M Goodwin
Journal:  Am J Psychiatry       Date:  2001-10       Impact factor: 18.112

7.  Differentiation of metabolic concentrations between gray matter and white matter of human brain by in vivo 1H magnetic resonance spectroscopy.

Authors:  Y Wang; S J Li
Journal:  Magn Reson Med       Date:  1998-01       Impact factor: 4.668

8.  Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder.

Authors:  G Rajkowska; A Halaris; L D Selemon
Journal:  Biol Psychiatry       Date:  2001-05-01       Impact factor: 13.382

9.  Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients.

Authors:  Bettina Pfleiderer; Nikolaus Michael; Andreas Erfurth; Patricia Ohrmann; Ulrike Hohmann; Matthias Wolgast; Martin Fiebich; Volker Arolt; Walter Heindel
Journal:  Psychiatry Res       Date:  2003-04-01       Impact factor: 3.222

10.  Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F 18.

Authors:  L R Baxter; M E Phelps; J C Mazziotta; J M Schwartz; R H Gerner; C E Selin; R M Sumida
Journal:  Arch Gen Psychiatry       Date:  1985-05
View more
  41 in total

1.  Phase-adjusted echo time (PATE)-averaging 1 H MRS: application for improved glutamine quantification at 2.89 T.

Authors:  Andrew P Prescot; Todd Richards; Stephen R Dager; Changho Choi; Perry F Renshaw
Journal:  NMR Biomed       Date:  2012-03-12       Impact factor: 4.044

Review 2.  Magnetic resonance spectroscopy studies of glutamate-related abnormalities in mood disorders.

Authors:  Cagri Yüksel; Dost Öngür
Journal:  Biol Psychiatry       Date:  2010-08-21       Impact factor: 13.382

Review 3.  Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders.

Authors:  Gerard Sanacora; Giulia Treccani; Maurizio Popoli
Journal:  Neuropharmacology       Date:  2011-08-03       Impact factor: 5.250

4.  Lamotrigine blocks NMDA receptor-initiated arachidonic acid signalling in rat brain: implications for its efficacy in bipolar disorder.

Authors:  Epolia Ramadan; Mireille Basselin; Jagadeesh S Rao; Lisa Chang; Mei Chen; Kaizong Ma; Stanley I Rapoport
Journal:  Int J Neuropsychopharmacol       Date:  2011-06-28       Impact factor: 5.176

Review 5.  Neurometabolites in schizophrenia and bipolar disorder - a systematic review and meta-analysis.

Authors:  Nina Vanessa Kraguljac; Meredith Reid; David White; Rebecca Jones; Jan den Hollander; Deborah Lowman; Adrienne Carol Lahti
Journal:  Psychiatry Res       Date:  2012-09-13       Impact factor: 3.222

6.  Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders.

Authors:  Yeni Kim; Krishna C Vadodaria; Zsolt Lenkei; Tadafumi Kato; Fred H Gage; Maria C Marchetto; Renata Santos
Journal:  Antioxid Redox Signal       Date:  2019-02-01       Impact factor: 8.401

7.  Trait-related alterations of N-acetylaspartate in euthymic bipolar patients: A longitudinal proton magnetic resonance spectroscopy study.

Authors:  Burç Aydin; Ayşegül Yurt; Necati Gökmen; Perry Renshaw; David Olson; Ayşegül Yildiz
Journal:  J Affect Disord       Date:  2016-09-09       Impact factor: 4.839

Review 8.  Dysregulation of the behavioral approach system (BAS) in bipolar spectrum disorders: review of theory and evidence.

Authors:  Snezana Urosević; Lyn Y Abramson; Eddie Harmon-Jones; Lauren B Alloy
Journal:  Clin Psychol Rev       Date:  2008-05-09

9.  Rapid enhancement of glutamatergic neurotransmission in bipolar depression following treatment with riluzole.

Authors:  Brian P Brennan; James I Hudson; J Eric Jensen; Julie McCarthy; Jacqueline L Roberts; Andrew P Prescot; Bruce M Cohen; Harrison G Pope; Perry F Renshaw; Dost Ongür
Journal:  Neuropsychopharmacology       Date:  2009-12-02       Impact factor: 7.853

Review 10.  Chronic treatment with anti-bipolar drugs causes intracellular alkalinization in astrocytes, altering their functions.

Authors:  Dan Song; Baoman Li; Enzhi Yan; Yi Man; Marina Wolfson; Ye Chen; Liang Peng
Journal:  Neurochem Res       Date:  2012-07-28       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.